Kedudukan dalam Saham
#21907
Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a... Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a global leader in umbilical cord blood preservation, serving clients across Taiwan and internationally. The company provides a comprehensive suite of stem cell banking services, encompassing the storage of general stem cells, mesenchymal stem cells, dental stem cells, adipose stem cells, and peripheral blood stem cells combined with immune cells. Beyond its core stem cell preservation, BIONET also conducts genetic testing services. Its product offerings further extend to anti-aging solutions leveraging stem cell technology, alongside its unique ANIKINE series. Additionally, the company is a pioneer in offering Exosome, an innovative cell-free therapeutic approach.
Harga Saham
$1.95
Disegerakkan terakhir: 2026-08-21
Perubahan (1 hari)
-0.16%
Perubahan (1 tahun)
-22.25%
Perdagangan BIONET Corp. (1784)
Harga 1784 dengan permodalan pasaran b
Modal pasaran bagi BIONET Corp.(1784)
Modal Pasaran: $98.22M
Sehingga August 2026, BIONET Corp. mempunyai modal pasaran sebanyak $98.22M. Ini menjadikan BIONET Corp. syarikat ke-21907th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran BIONET Corp. dari 2005 hingga 2026
1784 berbanding dengan 5 teratas yang paling popular stocks
| Harga 1784 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.211T
|
+5,305,687.88%
|
|
|
|
|
$4.547T
|
+4,629,023.42%
|
|
|
|
|
$4.162T
|
+4,237,791.23%
|
|
|
|
|
$3.593T
|
+3,657,784.50%
|
|
|
|
|
$2.793T
|
+2,843,354.94%
|
